ArticleExperimental and therapeutic medicine2017

Severe erythema multiforme-type drug eruption controlled by tumor necrosis factor-α antagonist: A case study.

Xin Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.